scorecardresearch
Add as a preferred source on Google
Friday, December 12, 2025
TopicUSFDA

Topic: USFDA

How the humble hydroxychloroquine has become India’s unlikely new global strategic asset

Donald Trump has labelled hydroxychloroquine a 'game-changer' in the fight against Covid-19. Indian pharma companies have gained significantly from this.

US FDA orders removal of ranitidine drugs from market over ‘carcinogen contamination’

Ranitidine is available in India under brand names of Aciloc and Zinetac but FDA specifically names Sanofi’s Zantac.

Torrent Pharma warned by US again, this time for using bacteria-contaminated water system

In the last 11 months, USFDA has issued 23 warning letters to Indian drugmakers. For Torrent Pharma, it's the third this year.

On Camera

IndiGo cancellations made TV news do the unexpected — question the Modi government

Republic TV was the harshest of them all: “The (civil aviation) minister has done a bad job,” said prime time anchor Arnab Goswami.

IndiGo’s profits dipped, most airlines sunk into losses last fiscal even as flier numbers soared

Despite growing passenger volume, 11 out of 14 carriers reported losses in 2023-24. IndiGo recorded profit of Rs 8,167 crore, which reduced to Rs 7.253 crore in 2024-25.

Dubai Tejas crash revives focus on advanced, fully automated safety systems

Dubai airshow crash & pilot death have rekindled concerns over pilot safety, and need for smarter automated systems that can step in when G-forces, temporary loss of consciousness hit the pilot.

Asim Munir & Pakistan’s Failed Marshal Doctrine

None of Pakistan’s PMs has lasted 5 years. That the current PM has given Asim Munir 5 years shows that of all military dictatorships history has seen, Pakistan’s is most creative.